Finance

Lists
Why is CGTX down ७.१७%?
Dive Deeper
CGTX:NASDAQ
Cognition Therapeutics Inc
US$ ०.८९
-७.१७%
(-०.०६९) 1D
US$ ०.९०
+१.२१% (+०.०११)
After hours
Closed: अक्टोबर १, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Open
US$ ०.९८
High
US$ ०.९९
Low
US$ ०.८९
Mkt. cap
८.४७ करोड
Avg. vol.
४.०० लाख
Volume
८४.००
52-wk high
US$ २.०५
52-wk low
US$ ०.५५
EPS
-US$ ०.२०
Beta
१.७९
Shares outstanding
९.५१ करोड
No. of employees
१४
Open
US$ ०.९८
High
US$ ०.९९
Low
US$ ०.८९
Mkt. cap
८.४७ करोड
Avg. vol.
४.०० लाख
Volume
८४.००
52-wk high
US$ २.०५
52-wk low
US$ ०.५५
EPS
-US$ ०.२०
Beta
१.७९
Shares outstanding
९.५१ करोड
No. of employees
१४
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
२८ मिनेट पहिले
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seeking Alpha
Seeking Alpha
·
२६ मिनेट पहिले
SPYM ETF: S&P 500 Monthly Dashboard For October
Investor's Business Daily
Investor's Business Daily
·
५९ मिनेट पहिले
Twilio To Join S&P 500 Index
Reuters
Reuters
·
४६ मिनेट पहिले
Wall St Week Ahead Spiking bond yields, midterms, earnings to test US stocks' typical fourth-quarter strength
About Cognition Therapeutics Inc
CEO-
Employees१४
Founded२००७ जनवरी १
Headquarters-
Sector-
Websitecogrx.com
Analyst ratings
Based on 1 analyst giving stock ratings to CGTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CGTX in the last 3 months
Highest
Current US$ ०.८९
US$ ३.०० (+२३६.६२%)
Average
US$ ३.०० (+२३६.६२%)
Lowest
US$ ३.०० (+२३६.६२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Maintained
US$ ३.००
+२३६.६%
09/21/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
US$ ४.००
+३४८.८%
05/08/2026
William Wood
B. Riley Securities
Buy
Maintained
US$ ३.००
+२३६.६%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
३७.७३ लाख
१.११ करोड
६१.२० लाख
५०.९७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२६.०२ लाख
२५.२४ लाख
२६.९७ लाख
२६.४१ लाख
Operating expense
६३.७५ लाख
१.३७ करोड
८८.१७ लाख
७७.३८ लाख
Total operating expenses
६३.७५ लाख
१.३७ करोड
८८.१७ लाख
७७.३८ लाख
Operating income
-६३.७५ लाख
-१.३७ करोड
-८८.१७ लाख
-७७.३८ लाख
Other non operating income
१४.४५ लाख
१.०३ करोड
४२.५२ लाख
३८.०९ लाख
EBT including unusual items
-४९.३० लाख
-३३.४३ लाख
-४५.७० लाख
-३९.३२ लाख
EBT excluding unusual items
-४९.३० लाख
-३३.४३ लाख
-४५.७० लाख
-३९.३२ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-४९.३० लाख
-३३.४३ लाख
-४५.७० लाख
-३९.३२ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.०६
-०.०२
-०.०५
-०.०४
Interest and investment income
-
-
-
-
Interest expense
-
-५.०० हजार
-५.०० हजार
-३.०० हजार
Net interest expenses
-
-५.०० हजार
-५.०० हजार
-३.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-६३.६० लाख
-१.३७ करोड
-८८.०६ लाख
-७७.२८ लाख
Gain or loss from assets sale
-
४१.०० हजार
५.०० हजार
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू